The incorporation of new medical treatments, procedures and technologies into the portfolio of health systems services must reach a triple objective in a balanced way: improving patient access to innovative solutions, sustainability of the system and compensation for innovation.

From our market access department, thanks to our experience and knowledge about the development of the medicines / technology and the existing regulations, we give the necessary support to obtain success in the negotiations with the agents involved. All of this is made possible from the “ad-hoc” creation of:

• Advisory Boards
• Stakeholders and cost databases
• Cost calculators (in Microsoft Excel or iPad format)
• Disease burden models (in Microsoft Excel or iPad format)
• Product Monographs
• Training on developed tools
• Articles and communications to congresses